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Abstract 
We have developed tools to explore social networks 
that  share  information  in  medical  forums  to  better 
understand the unmet informational needs of patients 
and family members facing cancer treatments.  We 
define metrics that demonstrate members discussing 
interleukin-2  receive  a  stronger  response  from  the 
melanoma discussion group than a typical topic. The 
interleukin-2 network has a different topology than 
the melanoma network, has a higher density, and its 
members are more likely to have a higher intimacy 
level  with  another  member  and  a  lower 
inquisitiveness  level than a typical melanoma user. 
Members  are  more  likely  to  join  the  interleukin-2 
network to answer a question than in the melanoma 
network (probability =.2 ±.05 p-value=.001).  Within 
the melanoma network 20% of the questions posed to 
the  community  do  not  get  an  answer.    In  the 
interleukin-2  network,  1.3%  of  the  questions  (one 
question) do not get a response.  
Introduction 
Online medical discussion groups give members who 
are dealing with a particular disease, an opportunity 
to  obtain  medical  information, coping strategies, as 
well  as  support  from  a  community  experiencing  a 
similar  circumstance.  The  benefit  and  utility  of  a 
medical forum is potentially twofold: educational and 
social. The social networks developed through the use 
of  medical  forums  focus  on  the  sharing  of 
information.  Normally,  relationships  do  not  exist 
among the members prior to joining the forum; the 
relationships  are  created  through  the  social 
interactions  on  the  forum.  These types of networks 
have  been  referred  to  as  knowledge-sharing  online 
social networks (OSN).
1 By sharing knowledge and 
discussing experiences, members create relationships 
and form a social network as well as increase their 
knowledge of the disease. This paradigm is different 
from other social networking sites that exploit already 
existing personal relationships.  
Clinical research has shown that cancer patients who 
join  in-person  discussion  groups  experience  a 
significantly improved quality of life, a significantly 
reduced pain level 
2 as well as a decrease in the three 
most  significant  stressors  for  cancer  patients: 
unwanted aloneness, loss of hope and loss of control.
3 
One  study  reports  a  decrease  in  depression  and 
reaction to pain for online support group members;
4 
while another reports a decrease in depression as well 
as perceived stress.
5 Our research defines metrics to 
quantify  different  response  levels  provided  by  an 
OSN. It complements the previously cited research.  
We construct social networks based on the directed 
communication  between  OSN  members  in  order  to 
understand the typical interactions between members.  
We focus on cancer forums and potentially terminal 
illness to better understand the informational needs, 
both met and unmet in a narrow time frame.  
We target interleukin-2 (IL-2) since it is prescribed to 
patients with a more advanced degree of melanoma 
(stage  iv).  We  wish  to  determine  if  the  melanoma 
forum reacts differently to these seriously ill patients. 
We hypothesize that users posing questions on IL-2 
will receive a stronger response from the network. 
41%  of  e-patients  have  read  and  6%  have  posted 
medical information or questions to an online web log 
or discussion group;
6 this usage shows that OSNs are 
an  important  informational  source  to  a  subset  of 
online  patients.  We  hypothesize  applying  social 
network analysis to an OSN will yield insight into the 
met and unmet needs of its members. 
Methodology 
Data source: The website www.cancercompass.com, 
is  an  online  cancer  data  source  sponsored  by  the 
Cancer  Treatment  Centers  of  America™.  Cancer 
compass has over thirty cancer forums and dates back 
to 2001. We harvest the posts, threads and users’ data 
from the melanoma forum using html parsers. Table 1 
displays statistics for the corpus collected Sept. 2009.  




Patient Survivor Doctor 
Nurse 
Member  Total 
Users  397  310  49  8  87  851 
Thread 
Creator  276  178  20  3  62  539 
Post  1175  858  97  122  156  2408 
Table 1. The number of users, threads and posts 
within the melanoma network. 
6   
A user is a member within the melanoma forum; there 
are  five  different  user  types:  caregiver,  patient, 
survivor, doctor/nurse and member. Users self-assign 
a user type when they register at the cancercompass 
website.  A  user  type  typically  describes  the 
relationship the user has with melanoma. A thread is 
a  discussion  found  on the melanoma forum; it is a 
collection  of  inter-related  posts.  We  assume  all 
threads should receive some sort of response. A user 
who poses a question to the forum is the creator of a 
thread.  When  other  users  respond  to  the  question, 
their responses are called posts and are appended to 
the thread. This contributing post is a connection to 
the thread’s creator.  
Melanoma social network: A social network consists 
of nodes and arcs.
6 We represent the melanoma forum 
as  a  social  network  where  the  nodes  represent  the 
members of the forum and the arcs are the directed 
communication  between  the  forum’s  members.  The 
directed communication is from the answerer to the 
questioner.  The  relative  thickness  of  an  edge 
represents  the  number  of  directed  communication 
between  the  two  members.  Non-directed 
communication  such  as  questions  posed  to  the 
community-at-large is modeled as an attribute of the 
user. It is the inquisitiveness level of the user and is 
represented  by  the  relative  size  of  the  user’s  node 
within  the network. In general, questions provide a 
mechanism for members to potentially connect, while 
answers  are  the  manifestation  of  a  connection 
between two members. Within the network, a node is 
created because of a member’s interest in the forum’s 
topic, whereas an arc is created because of a user’s 
willingness  to  actively  contribute  to  a  thread’s 
discussion.   
   Care 
giver 
Patient Survivor Doctor 
Nurse 
Member Total 
Users  133  81  9  2  10  235 
Thread 
Creator  44  23  3  0  5  75 
Post  294  187  15  31  12  539 
Table 2. The number of users, posts and threads 
within the IL-2 network. 
IL-2  Network:  We  identify  the  threads,  posts  and 
users that have discussed IL-2 within the melanoma 
OSN. Since the network is defined by the concept IL-
2, the IL-2 network is not a mere extraction of a sub-
network from the melanoma network. The nodes and 
the  arcs  are  a  subset  of  the  melanoma  network; 
however  the  edge  weights  and  node  weights 
represented  by  the  node  size  and  arc  thickness 
respectively,  will  vary  between  the  two  networks 
since the number of questions and answers on IL-2 
versus all topics may be different for the users within 
the two networks.  
We  use  the  presence  of  the  terms:  interleukin, 
Interleukin-2, IL-2, aldesleukin, proleukin®, as well 
as  the  regular  expression  interleuk??  to  identify 
threads  discussing  IL-2  treatment.  The  size  of  the 
network is described in Table 2.  
Procedure:  We  define  metrics  that  quantify  the 
response provided by a network to its members. We 
compare a specific topic’s network response metrics 
to  the  response  metrics  found  within  the  total 
network. We compare the social interactions within 
the IL-2 threads to the social interactions within the 
melanoma threads. 
Node classes: There are four classes of nodes: nodes 
that  receive  information,  nodes  that  provide 
information,  nodes  that  receive  and  provide 
information  and  nodes  that  do  neither.  Nodes  that 
provide information are producers; nodes that receive 
information  are  consumers  and  nodes  that  provide 
and receive information are facilitators. The network 
may service a consumer’s request or not. We define 
p-satisfied  consumers  as  consumers  whose  needs 
have a higher probability of being satisfied. 
Hub/authority  analysis:  We  identify  the  influential 
producers  and  the  p-satisfied  consumers  using 
hub/authority analysis.
8 A hub node is a node that has 
many outgoing arcs but very few incoming arcs.
8 An 
authority node is a node that has many incoming arcs 
but few outgoing arcs. Since our network models data 
transfer,  the  hubs  are  the  users  providing  the  most 
information,  the  most  active  producers.  Authorities 
are the users who ask for information and receive a 
large  response  from  the  network,  the  p-satisfied 
consumers.  Users  identified  as  both  a  hub  and  an 
authority  are  nodes  that  have  many  incoming  and 
outgoing  arcs,  the  most  successful  facilitators  in 
communication. Facilitators pass information and are 
passed information, they encourage communication. 
Metrics: The responsiveness metrics are: the average 
length  of  a  thread  (measured  in  the  number  of 
responses), the average number of days the thread is 
active (from question posted to last response) and the 
percentage of unanswered questions. 
Visualization:  We  visualize  the  networks  using  the 
open-source visualization tool: Pajek.
6 All networks 
were  drawn  using  the  Kamada-Kawai  algorithm.
9 
Kamada-Kawai  is  a  force-directed  layout  algorithm 
that attempts to position nodes on the space so that 
the geometric (Euclidean) distance between the nodes 
7   
is as close as possible to the graph-theoretic (path) 
distance  between  them.  Nodes  at  the  center  of  the 
network  are  more  highly  connected  to  other  nodes 
than nodes found in the periphery of the network. 
Results 
Using  the  defined  response  metrics,  we  show  IL-2 
threads  receive  a  stronger  response  from  the 
melanoma  network  than  a  typical  topic.  We  show 
there  is  a  significant  difference  in  the  method  in 
which users join the two networks. We also show the 
topography  and  the  social  structures  of  the  two 
networks are different; however the same influential 
users are involved within both networks.  
Melanoma network: Figures 1 and 2 use both shape 
and color to distinguish the user types: red square = 
patient,  blue  circle  =  caregiver,  salmon  circle  = 
survivor, green diamond = doctor/nurse, and purple 
triangle = member. 
 
Figure 1. Melanoma Network. 
The  melanoma  network  has  two  distinct  unequal-
sized groups that are aligned along the y-coordinate. 
The  left  side  group  has  patients  centered  and 
caregivers in the periphery. The right side group has a 
prominent  doctor/nurse  surrounded  by  caregivers 
with patients in the periphery.  
IL-2 Network: The star relationship is prominent in 
the  IL-2  network;  it  resembles  a  flower  in  the 
Kamada-Kawai  algorithm.  The  star  relationship 
identifies nodes that are central in information flow. 
In  the  IL-2  network,  the  star’s  central  nodes  are 
consumers of information and the non-central nodes 
are  the  providers  of  information.  Figure  2  shows 
many consumers receiving information from multiple 
sources. Many of the producers are central but others 
are even more peripheral than the consumer node.   
Comparing networks: We differentiate the networks 
by comparing: 1) the density, 2) the arc weights, 3) 
the node weights, 4) the initial user action and 5) the 
effect  of  user  type  on  activity  level  and  on 
membership duration in the two networks. 
 
Figure 2. IL-2 network. 
Using user type as a factor, a nonparametric Kruskal-
Wallis  ANOVA  test  determines  both  number  of 
interactions and length of membership is affected by 
the user type in the melanoma network (p-value = .01, 
p-value=.007 respectively). However, within the IL-2 
network, the number of interactions and the length of 
membership are not influenced by the user type.  We 
use  the  nonparametric  Kruskal-Wallis  test  because 
the data is not normally distributed.  
We consider the initial action a user performs when 
joining both networks. A user may choose to pose a 
question or answer a question. Users are more likely 
to join the IL-2 network to answer a question than in 
the melanoma network (.2 ±.05 p-value=.001). 
The density of a network is defined as the number of 
lines,  expressed  as  a  proportion  of  the  maximum 
possible number of lines.
8 The density of the IL-2 and 
the melanoma network is .006 and .002 respectively. 
The  IL-2  network  is  three  times  as  dense  as  the 
melanoma network. 
Intimacy level of Pairs




Line Value 1 Line Value 2 Line Value 3 Line Value 4 Line Value 5
Line Value 6 Line Value 7  
Figure  3.  Frequency  distribution  of  the  arc 
weights, arc weights represent intimacy level. 
Arc  weight  represents  the  number  of  times  a 
particular  user  communicated  to  another  user.  A 
8   
higher weight means more communication instances 
between  two  users.  More  communication  instances 
increase the intimacy of the two users. Figure 3 shows 
the IL-2 network has 8.16% of its arcs with weight > 
2  whereas  the  melanoma  network  has 4.94% of its 
arcs  with  weight  >  2.    Proportionally,  the  IL-2 
network has more intimate pairs. 
Node  weight  represents  the  number  of  questions 
asked by a user and corresponds to the inquisitiveness 
level of the user. Members of the melanoma network, 
in  general,  are  more  inquisitive  than  the  IL-2 
members. 90.95% of the melanoma consumers ask 2 
or  fewer  questions  whereas  97.44%  of  the  IL-2 
consumers ask 2 or fewer questions.  Only 29% of the 
IL-2 consumers ask more than 1 question compared 
to 49% of the melanoma consumers.  
Inquisitive level of users
0% 20% 40% 60% 80% 100%
Melanoma
Il-2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  
Figure  4.  Frequency  distribution  of  the  node 
weights, node weight represents inquisitive level. 
Response  Variables:  Our  fundamental  measurement 
of response is receiving at least one answer from a 
community member for a question broadcasted to the 
community.  Within  the  melanoma  network  20%  of 
the questions posed to the community do not get an 
answer. In the IL-2 network, 1.3% of the questions 
(one question) do not get a response (Table 3, row 1).  
  Melanoma   IL-2  
No response percent   20%  1.3% 
Users  per thread 
     Median,  Mean 
     Standard Deviation 
 
3,  4.468 
3.906 
 
6,  7.18 
4.8314 
Threads’ active days 
Median,  Mean 







Table 3. Response variables for the networks. 
The  number  of  users  per  thread  (Table  3,  row  2) 
shows twice as many users respond to questions on 
IL-2 than on a typical topic. The number of days a 
thread  is  active  (Table  3  row  3),  shows  that  IL-2 
threads are a source of communication for a longer 
period of time. 
Influential users: We identify influential users using 
hub/authority analysis of the network.
8 The influential 
producers are colored red, the p-satisfied consumers 
are  colored  yellow  and  the  facilitators  are  colored 
green. In both networks, the same one facilitator and 
three influential providers were identified. Out of the 
eight  p-satisfied  consumers  found  in  the  IL-2 
network,  three  were  also  identified  as  p-satisfied 
consumers in the top 15 p-satisfied consumers of the 
melanoma network.   
 
Figure 5. A grayscale magnification of the center 
of  the  melanoma  network  with  red,  most  active 
provider  nodes,  a  green  facilitator  node  and 
yellow, p-satisfied consumer nodes.  
 
Figure 6. A grayscale magnification of the center 
of the IL-2 network (nodes as defined in Figure 5).  
Discussion 
High-dose IL-2 therapy is a very difficult process; its 
patients experience a variety of side effects ranging 
from tachycardia to peeling skin. It has been shown to 
be extremely successful in a small percentage of stage 
iv melanoma patients; its 5-year survival rate is 10% 
versus  2%  for  chemotherapy.  While  IL-2  provides 
hope for patients with an almost terminal illness, this 
treatment is a great source of distress for patients and 
their families. Users experiencing IL-2 treatment need 
more support than the norm and may receive it from 
9   
an  OSN.    Users  seeking  IL-2  information  get  a 
stronger  response  from  the  OSN  in  terms  of  the 
number  of  people  reacting  to  the  questioner,  the 
likelihood of receiving an answer, and the length in 
time the thread stays active.  
Users providing the strongest response (facilitator and 
producers) are the same in both networks (Figures 5 
and 6), revealing the importance of these users within 
the community. The facilitator node supports a large 
portion of the melanoma network and has no other 
influential  neighbors.  Since  it  is  a  facilitator  it  not 
only  provides  information,  it  also  receives 
information  from  its  surrounding  non-influential 
nodes.  The  facilitator  is  a  patient  and  most  of  its 
neighbors are also patients, this similar characteristic 
may  explain  its  neighbors’  willingness  to  perform 
directed  communication.  The  highest-ranking 
producer  (doctor)  has  two  neighbors  that  are  also 
influential  producers  (both  caregivers).  All  three 
nodes provide information but have not successfully 
encouraged conversation between themselves and the 
surrounding consumers. 
Despite  the  support  provided  by  the  influential 
providers,  20%  of  the  questions  posed  to  the 
melanoma community do not get an answer. In the 
IL-2 network, 1.3% of the questions (one question) 
do not get a response. We determined the unanswered 
question asks for opinions on the difference between 
IL-2  treatment  and  TK1258  treatment  for  ocular 
melanoma.  Ocular  melanoma  is  a  rare  form  of 
melanoma with an estimated incidence of 6 per one 
million per year.
11 This is a question whose answer 
may not be known within the community. 
IL-2 consumers receive more responses because IL-2 
network members are less dependent on receiving a 
response from an influential user.  The IL-2 network 
is  more  densely  connected  than  the  melanoma 
network;  this  means  the  users  responding  to  the 
questions are more varied.  Many of the providers are 
found in the periphery (non-central nodes in the star 
relation Figure 2), showing that many consumers are 
more central to the IL-2 network than some providers. 
A  user  is  more  likely  to  join  the  IL-2  network  to 
answer a question; this action provides support to an 
existing member of the IL-2 community. 
Conclusion 
We have demonstrated that SN tools can visualize the 
interactions within an OSN and provide insight into 
its communication patterns. We defined novel metrics 
and applied well-established SN analysis techniques 
to  demonstrate  the  differences  in  an  OSN’s 
responsiveness to a particular topic (IL-2). We plan 
to characterize threads receiving a low or no response 
from the melanoma forum. 
We  have  shown  that  one  topic  (IL-2)  in  our  OSN 
elicits  a  strong  response  when  compared  to  the 
overall network. Understanding the relative strengths 
of a response for different topics within an OSN may 
indicate  targets  of  opportunity  for  information 
interventions on behalf of patients and their families. 
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